MBX Biosciences, Inc.
MBX
$10.77
$0.282.67%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Net Income | -90.16% | -- | -- | -- | |
| Total Depreciation and Amortization | 55.41% | -- | -- | -- | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 106.36% | -- | -- | -- | |
| Change in Net Operating Assets | 725.44% | -- | -- | -- | |
| Cash from Operations | -71.00% | -- | -- | -- | |
| Capital Expenditure | -577.52% | -- | -- | -- | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -418.61% | -- | -- | -- | |
| Cash from Investing | -419.27% | -- | -- | -- | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | 23,573.21% | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -7.31% | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -14,370.00% | -- | -- | -- | |
| Cash from Financing | 238.21% | -- | -- | -- | |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | 198.24% | -- | -- | -- | |